Filter News
Area of Research
- (-) Neutron Science (7)
- (-) Nuclear Science and Technology (1)
- Advanced Manufacturing (1)
- Biological Systems (1)
- Biology and Environment (14)
- Clean Energy (28)
- Computational Biology (1)
- Computational Engineering (1)
- Computer Science (2)
- Fusion and Fission (1)
- Isotopes (2)
- Materials (11)
- Materials for Computing (2)
- National Security (4)
- Quantum information Science (1)
- Supercomputing (11)
News Topics
- (-) Bioenergy (2)
- (-) Biomedical (4)
- (-) Composites (1)
- (-) Machine Learning (1)
- (-) Transportation (1)
- 3-D Printing/Advanced Manufacturing (2)
- Advanced Reactors (2)
- Artificial Intelligence (2)
- Biology (2)
- Chemical Sciences (1)
- Clean Water (1)
- Computer Science (7)
- Coronavirus (2)
- Energy Storage (2)
- Environment (3)
- Fusion (1)
- High-Performance Computing (1)
- Isotopes (2)
- Materials (2)
- Materials Science (7)
- Microscopy (1)
- Molten Salt (1)
- Nanotechnology (2)
- Neutron Science (22)
- Nuclear Energy (7)
- Physics (3)
- Quantum Computing (1)
- Quantum Science (2)
Media Contacts
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
Illustration of the optimized zeolite catalyst, or NbAlS-1, which enables a highly efficient chemical reaction to create butene, a renewable source of energy, without expending high amounts of energy for the conversion. Credit: Jill Hemman, Oak Ridge National Laboratory/U.S. Dept. of Energy
ORNL computer scientist Catherine Schuman returned to her alma mater, Harriman High School, to lead Hour of Code activities and talk to students about her job as a researcher.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.
Scientists at the Department of Energy’s Oak Ridge National Laboratory have created a recipe for a renewable 3D printing feedstock that could spur a profitable new use for an intractable biorefinery byproduct: lignin.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
Researchers are looking to neutrons for new ways to save fuel during the operation of filters that clean the soot, or carbon and ash-based particulate matter, emitted by vehicles. A team of researchers from the Energy and Transportation Science Division at the Department of En...